Zobrazeno 1 - 6
of 6
pro vyhledávání: '"FJ Garcia Moreno"'
Autor:
V. Escudero Vilaplana, I Taladriz Sender, J Vicente Valor, R Collado Borell, M Sanjurjo Sáez, JL Revuelta Herrero, C Villanueva Bueno, FJ Garcia Moreno, E González-Haba Peña
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Cancer patients are a vulnerable population for SAR-CoV-2 infection Aim and objectives The aim of our study was to describe the epidemiology and clinical course of patients with cancer infected with SARS-Cov-2, attending hos
Autor:
C Villanueva Bueno, A Melgarejo Ortuño, B Somoza Fernandez, J Vicente Valor, FJ Garcia Moreno, C Rodriguez Gonzalez, E Chamorro de Vega, A. De Lorenzo Pinto, I Taladriz Sender, M Sanjurjo Sáez, A Herranz Alonso
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Identification of the angiotensin converting enzyme (ACE2) as a target of the SARS-CoV-2 virus raises questions about a possible change in the clinical course of this infection associated with inhibitors of the renin-angiote
Autor:
R. García Sánchez, A Melgarejo Ortuño, S García Sánchez, Má Amor García, C Ortega Navarro, FJ Garcia Moreno, P Ruiz Briones, M Sanjurjo Sáez, A Herranz Alonso, Á Narrillos Moraza
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Due to the rising rate of antibiotic resistance over the past years, healthcare authorities have developed different strategies to solve this problem. In Spain, the Heath Care Service of Madrid (SERMAS) published the ‘Anti
Autor:
M. N. Sánchez Fresneda, S García Sánchez, FJ Garcia Moreno, E González-Haba Peña, M Sanjurjo Sáez, A Herranz Alonso, B. Marzal Alfaro, R Collado Borrell, A. Mur Mur, E García Martín
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The development of checkpoint inhibitors-based immunotherapy has completely changed the therapeutic approach of metastatic melanoma (MM). In parallel, research activity concerning this tumour continues at a very high level through a large
Autor:
M Sanjurjo Sáez, S. Pernia Lopez, RM Romero Jiménez, A Melgarejo Ortuño, C Ortega Navarro, A Herranz Alonso, FJ Garcia Moreno, JL Revuelta Herrero
Publikováno v:
Eur J Hosp Pharm
Background Parenteral nutrition has been classified as a high-alert medication. In recent years, quality organisations such as the Joint Commission require hospitals to conduct proactive risk assessments of high-risk processes. Purpose To describe th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e24bf4e29aa7ca9d8b98abaee1c6b5c
https://europepmc.org/articles/PMC7535544/
https://europepmc.org/articles/PMC7535544/
Publikováno v:
Eur J Hosp Pharm
Background Congenital myasthenic syndromes (CMS) are a group of inherited neuromuscular disorders caused by defects at the neuromuscular junction. The defect in choline acetyltransferase (CHAT) causes a type of presynaptic CMS characterised by hypoto